Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy for recurrent spontaneous abortion

C B Coulam1

  • 1Genetics & IVF Institute, Fairfax, Virginia, USA.

Early Pregnancy : Biology and Medicine : the Official Journal of the Society for the Investigation of Early Pregnancy
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromatin intact human sperm recovery is higher following glass wool column filtration as compared with density gradient centrifugation.

Andrologia·2011
Same author

P53 tumor suppressor factor, plasminogen activator inhibitor, and vascular endothelial growth factor gene polymorphisms and recurrent implantation failure.

Fertility and sterility·2008
Same author

Vascular endothelial growth factor gene polymorphism and implantation failure.

Reproductive biomedicine online·2008
Same author

Discordance among blastomeres renders preimplantation genetic diagnosis for aneuploidy ineffective.

Journal of assisted reproduction and genetics·2007
Same author

p53 tumour suppressor gene polymorphism is associated with recurrent implantation failure.

Reproductive biomedicine online·2006
Same author

Role of p53 codon 72 polymorphism in recurrent pregnancy loss.

Reproductive biomedicine online·2006
Same journal

Can luteal phase serum estradiol concentrations predict karyotypes of spontaneous abortions?

Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy·1999
Same journal

Fetal rat brains contain luteinizing hormone/human chorionic gonadotropin receptors.

Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy·1999
Same journal

A re-examination of the association of 'early pregnancy factor' activity with fractions of heterogeneous molecular weight distribution in pregnancy sera.

Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy·1999
Same journal

The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies.

Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy·1999
Same journal

Less miscarriage in pregnancy following Tamoxifen treatment of infertile patients with luteal phase dysfunction as compared to clomiphene treatment.

Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy·1999
Same journal

The relationship between trophoblast differentiation and the production of bioactive hCG.

Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy·1999
See all related articles

Identifying specific markers for recurrent pregnancy loss (RPL) is crucial for effective immunotherapy. Antiphospholipid antibodies, NK cells, and chromosomal analysis help predict treatment response for RPL patients.

Area of Science:

  • Reproductive Immunology
  • Genetics
  • Obstetrics

Background:

  • Recurrent pregnancy loss (RPL) affects many women, necessitating safe and effective treatments.
  • Patient heterogeneity in RPL requires specific markers to guide treatment selection.
  • Current treatment strategies lack precise patient stratification, impacting outcomes.

Purpose of the Study:

  • To identify predictive markers for immunotherapy response in women with recurrent pregnancy loss.
  • To stratify RPL patients for targeted treatments like heparin, aspirin, IVIg, and leukocyte immunization.
  • To evaluate the clinical utility of genetic and immunological markers in RPL management.

Main Methods:

  • Review of existing literature on markers associated with RPL and treatment outcomes.

Related Experiment Videos

  • Analysis of patient subgroups based on immunological profiles (antiphospholipid antibodies, NK cells, leukocyte antibodies).
  • Consideration of genetic factors, including chromosomal abnormalities in abortuses.

    • Main Results:

    • Antiphospholipid antibodies predict response to heparin and aspirin.
    • Elevated maternal NK cells and loss of normal embryos predict IVIg response.
    • Absence of specific antibodies predicts response to leukocyte immunization, though with limited efficacy (60% livebirth rate).

    Conclusions:

    • Specific immunological markers can identify RPL patients likely to benefit from targeted immunotherapies.
    • IVIg shows higher success rates (70%) compared to leukocyte immunization, particularly in specific patient groups.
    • Karyotyping of pregnancy losses is essential to identify aneuploidy, as these cases are unlikely to respond to immunotherapy.